Copenhagen Research Centre for Mental Health - CORE, Mental Health Centre Copenhagen, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark.
Center of Psychiatry Amager, Copenhagen, Denmark.
Schizophr Bull. 2023 Mar 15;49(2):297-308. doi: 10.1093/schbul/sbac103.
Through decades the clinical recovery outcomes among individuals diagnosed with schizophrenia have been highly inconsistent ranging from 13.5% to 57%. The primary objective of this updated examination was to report the pooled estimate and explore various moderators to improve the understanding of the course of schizophrenia.
A systematic literature search was set up on PubMed, PsycInfo, and EMBASE until January 13th, 2022. Both observational and interventional studies among cohorts of individuals with the first episode of schizophrenia reporting on clinical recovery were included. The PRISMA 2020 statement was used and data was extracted for a random-effects meta-analysis, meta-regression, and sensitivity analyses. Risk of bias was assessed using The Newcastle-Ottawa Scale.
A 20.8% (95% CI = 17.3 to 24.8) recovery rate was found among 26 unique study samples (mean trial duration, 9.5 years) including 3877 individuals (mean age, 26.4 years). In meta-regression none of the following study characteristics could uncover the diverse reported recovery rates; age at inclusion (P = .84), year of inclusion (P = .93), follow-up time (P = .99), drop-out rate (P = .07), or strictness of the recovery criteria (P = .35). Furthermore, no differences in recovery were found between early intervention services (EIS; 19.5%; 95% CI = 15.0 to 24.8) compared to other interventions (21%; 95% CI = 16.9 to 25.8), P = .65.
A clinical recovery rate of approximately 21% was found with minimum impact from various moderators. The rate was not different comparing EIS with other interventions implying that new initiatives are needed to improve the rate of recovery.
数十年来,精神分裂症患者的临床康复结果高度不一致,范围从 13.5%到 57%。本次更新检查的主要目的是报告汇总估计值,并探讨各种调节因素,以增进对精神分裂症病程的理解。
在 PubMed、PsycInfo 和 EMBASE 上建立了系统的文献检索,截至 2022 年 1 月 13 日。纳入了报告首次精神分裂症发作患者临床康复的队列观察性和干预性研究。采用 PRISMA 2020 声明,并提取数据进行随机效应荟萃分析、荟萃回归和敏感性分析。使用纽卡斯尔-渥太华量表评估偏倚风险。
在 26 项独特的研究样本(平均试验持续时间 9.5 年)中,发现有 20.8%(95%CI=17.3 至 24.8)的康复率,其中包括 3877 名个体(平均年龄 26.4 岁)。在荟萃回归中,以下研究特征均无法揭示报告的不同康复率:纳入时的年龄(P=0.84)、纳入年份(P=0.93)、随访时间(P=0.99)、脱落率(P=0.07)或康复标准的严格程度(P=0.35)。此外,早期干预服务(EIS;19.5%;95%CI=15.0 至 24.8)与其他干预措施(21%;95%CI=16.9 至 25.8)之间的康复率无差异,P=0.65。
发现临床康复率约为 21%,受各种调节因素的影响最小。EIS 与其他干预措施相比,康复率无差异,这表明需要采取新的举措来提高康复率。